Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Y.S.P. Southeast Asia Holding Bhd's share price is RM2.04.
Y.S.P. Southeast Asia Holding Bhd's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was RM2.56. Hence, Y.S.P. Southeast Asia Holding Bhd's PS Ratio for today is 0.80.
Good Sign:
Y.S.P. Southeast Asia Holding Bhd stock PS Ratio (=0.8) is close to 10-year low of 0.76.
During the past 13 years, Y.S.P. Southeast Asia Holding Bhd's highest 3-Year average Revenue per Share Growth Rate was 9.20% per year. The lowest was -13.20% per year. And the median was 3.80% per year.
Back to Basics: PS Ratio
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Y.S.P. Southeast Asia Holding Bhd PS Ratio Related Terms
Y.S.P. Southeast Asia Holding Bhd PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Y.S.P. Southeast Asia Holding Bhd's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Y.S.P. Southeast Asia Holding Bhd PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Y.S.P. Southeast Asia Holding Bhd's PS Ratio distribution charts can be found below:
* The bar in red indicates where Y.S.P. Southeast Asia Holding Bhd's PS Ratio falls into.
Y.S.P. Southeast Asia Holding Bhd PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Y.S.P. Southeast Asia Holding Bhd's Share Price of today is RM2.04. Y.S.P. Southeast Asia Holding Bhd's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM2.56.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) has a PS Ratio of 0.80 as of Jul. 19, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. This is 23% below median its historical median of 1.04. Over the past decade, Y.S.P. Southeast Asia Holding Bhd's PS Ratio has ranged from 0.76 to 1.70. According to the industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #194 out of 954 companies in the Drug Manufacturers industry, placing it in the top 20.3%.
Is Y.S.P. Southeast Asia Holding Bhd's PS Ratio too high?
Y.S.P. Southeast Asia Holding Bhd's current PS Ratio of 0.80 is 23% below median its 10-year median of 1.04. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 1.70. The Drug Manufacturers industry median PS Ratio is 2.32. Y.S.P. Southeast Asia Holding Bhd's value of 0.80 is 65.5% below this industry median. Based on the distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #194 out of 954 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Y.S.P. Southeast Asia Holding Bhd has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Y.S.P. Southeast Asia Holding Bhd's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #194 out of 954 companies for PS Ratio. This places Y.S.P. Southeast Asia Holding Bhd in the top 20% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.32. Y.S.P. Southeast Asia Holding Bhd's value of 0.80 is 65.5% below this benchmark. Historically, Y.S.P. Southeast Asia Holding Bhd's own PS Ratio has ranged from 0.76 to 1.70 over the past decade. While the company's 10-year median is 1.04 vs. the industry median of 2.32, Y.S.P. Southeast Asia Holding Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.32, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Y.S.P. Southeast Asia Holding Bhd's current PS Ratio of 0.80 is 65.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Y.S.P. Southeast Asia Holding Bhd's current PS Ratio is 0.80, which is 23% below median its own 10-year median of 1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Y.S.P. Southeast Asia Holding Bhd stock overvalued right now?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) is currently considered Modestly Undervalued. The stock's GF Value™ is RM2.41, compared to a current price of RM2.04 — trading 15.4% below its estimated fair value. The current PS Ratio is 0.80, which is 23% below median its 10-year median of 1.04 and 65.5% below the Drug Manufacturers industry median of 2.32. Y.S.P. Southeast Asia Holding Bhd's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Y.S.P. Southeast Asia Holding Bhd (XKLS:7178), the current PS Ratio is 0.80 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Overvalued in 2026?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd stock appears to be undervalued.
The current stock price of RM2.04 is trading 15.4% below its estimated GF Value™ of RM2.41.
GuruFocus considers Y.S.P. Southeast Asia Holding Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7178:
PS Ratio: 0.80 (23% below median its 10-year median of 1.04)
GF Value™: RM2.41 vs. price of RM2.04 (15.4% below fair value)
Industry Position: 65.5% below the Drug Manufacturers median (#194 of 954)
No single metric tells the full story. See the XKLS:7178 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Y.S.P. Southeast Asia Holding Bhd Business Description
Y.S.P. Southeast Asia Holding Bhd is an investment company, that engages in the pharmaceutical business, and provision of management services. The company operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trading in various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is derived from Malaysia.
80GF Score
Get the complete analysis for XKLS:7178
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7178 has been successfully added to your 
